Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-26-025474
Filing Date
2026-05-27
Accepted
2026-05-27 19:23:30
Documents
1
Period of Report
2026-05-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5803
  Complete submission text file 0001493152-26-025474.txt   7182
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Issuer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O HCW BIOLOGICS, INC. 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address
Byam Rebecca (Reporting) CIK: 0001866256 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40591 | Film No.: 261028085